OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
September 30, 2026 — OS Therapies reports 75% 2-year survival in osteosarcoma trial, plans regulatory filings for OST-HER2 with FDA and UK MHRA by year-end 2025.
Curated Health Wellness News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
September 30, 2026 — OS Therapies advances OST-HER2 immunotherapy for osteosarcoma with FDA RMAT designation. Phase 2b results show significant survival improvement. Potential 2026 launch with commercial partner Eversana.
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
May 31, 2026 — Cingulate advances CTx-1301 ADHD treatment with FDA acceptance and 2026 PDUFA date. Stonegate updates coverage as company prepares for potential commercial launch.
Lexaria Hits 60 Global Patents, Urges Shareholder Vote for 2026 Meeting
January 22, 2026 — Lexaria Bioscience reaches 60 global patents, including new grants for hypertension and diabetes treatments. Shareholders urged to vote at the 2026 Annual Meeting for corporate governance.
HeartBeam Appoints New CCO to Drive Cardiac Tech Commercialization
January 22, 2026 — HeartBeam appoints Bryan Humbarger as CCO to lead commercial strategy for its FDA-cleared cardiac monitoring system, enhancing portable ECG technology for arrhythmia and heart attack detection.
AI Creates Digital Twin of Brain Cancer to Predict Treatment Outcomes
January 22, 2026 — University of Michigan researchers develop AI-powered digital twin of brain cancer to predict treatment outcomes. This innovation could revolutionize personalized cancer care and improve patient survival rates.
Stroke Conference Expands with Focus on Nursing, Equity, and Brain Health
January 22, 2026 — American Stroke Association adds pre-conference symposiums on nursing, brain health, and equity to its 2026 International Stroke Conference in New Orleans.
Dr. Simovic Named Castle Connolly Top Doctor for 13th Straight Year
January 22, 2026 — Drasko Simovic, MD, earns 2026 Castle Connolly Top Doctor honor for 13th year, leading EMG Laboratory in advanced neuromuscular diagnostics with EMG and ultrasound.
Ethio-American Doctors Group Defends $12M Medical City Project Amid Land Dispute
January 22, 2026 — Ethio-American Doctors Group addresses allegations about their $12M Medical City Center in Addis Ababa, detailing project progress and bureaucratic delays.
Cayenne Wellness Marks 25 Years with Star-Studded Gala for Sickle Cell Support
January 22, 2026 — Cayenne Wellness Center celebrates 25 years with a fundraising gala featuring celebrities to support sickle cell disease programs. Learn about the event and sponsors.
Healthspan Coalition Unites 300 Groups to Extend Healthy Years for All
January 22, 2026 — Healthspan Action Coalition unites 300 organizations to advance healthy longevity through geroscience, policy, and cross-sector collaboration, aiming to extend healthspan globally.
LIXTE Biotech & De La Soul Launch Health Equity Summit at Morehouse
January 21, 2026 — LIXTE Biotechnology sponsors De La Soul's Good Health Summit at Morehouse College, focusing on health equity for Black communities through cancer research and wellness advocacy.
LIXTE Biotech & De La Soul Launch Health Equity Summit at Morehouse
January 21, 2026 — LIXTE Biotechnology sponsors Good Health Summit with De La Soul at Morehouse College, advancing health equity through cultural engagement and cancer research innovation.
New Antibodies Supercharge Immune System to Fight Cancer
January 21, 2026 — Scientists at Southampton University develop new antibodies that boost the immune system's cancer-killing ability, enhancing immunotherapy effectiveness. Learn how this innovation could transform cancer treatment.
Heart Disease & Stroke Deaths Decline, But Remain Top U.S. Killers
January 21, 2026 — AHA's 2026 report shows heart disease & stroke deaths declined but remain the #1 & #4 U.S. killers. Alarming rise in young adult stroke deaths & nearly 90% have early CKM syndrome risk.
Protheragen Enhances Drug Development with Advanced Analysis Solutions
January 21, 2026 — Protheragen offers comprehensive drug analysis services, including stability and impurity testing, to enhance pharmaceutical development and ensure regulatory compliance.
Optimum Pest Control Tackles NYC Cockroach Health Risks with Eco-Friendly Solutions
January 21, 2026 — Optimum Pest Control offers professional cockroach removal in NYC with eco-friendly solutions. Learn about health risks and tailored treatments for infestations.
Creative Biolabs Expands Liposomal Drug Delivery Services to Overcome Formulation Challenges
January 21, 2026 — Creative Biolabs expands liposomal formulation services for drug delivery, addressing encapsulation efficiency and stability challenges for proteins, small molecules, and vaccine adjuvants.
Lixte Biotech to Showcase Cancer Drug LB-100 at 2026 Investor Conference
January 20, 2026 — Lixte Biotechnology announces CEO Geordan Pursglove will present LB-100, a first-in-class cancer drug, at the 2026 DealFlow Discovery Conference, highlighting clinical trials and investor engagement.
Austrian Midwife's Organic Baby Brand Expands in US with Trust-First Approach
January 20, 2026 — Austrian midwife Sarah Lares expands her organic baby brand The Midwife in Vienna to the US market, offering minimalist products backed by 20 years of clinical experience.